Status:

COMPLETED

Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Conditions:

Cocaine-Related Disorders

Eligibility:

All Genders

18-50 years

Phase:

PHASE2

Brief Summary

Cocaine abuse continues to represent a significant public-health concern. Cocaine likely creates its addictive effects by increasing levels of dopamine, a chemical found in the brain. GABA agonists ar...

Detailed Description

Cocaine likely creates its reinforcing and addictive effects by increasing levels of dopamine, a brain neurotransmitter. GABA agonists are chemicals that have the opposite effect by inhibiting the rel...

Eligibility Criteria

Inclusion

  • Recent use of cocaine
  • Meets DSM-IV diagnostic criteria for psychoactive substance abuse or dependence for cocaine
  • Positive drug urine screen for cocaine at time of initial screening interview
  • Reports self-administration of at least 1,260 mg of cocaine during the 4 weeks prior to study start date
  • Body Mass Index (BMI) of less than 29
  • Females must use an effective form of contraception throughout the study

Exclusion

  • Meets DSM-IV diagnostic criteria for psychoactive substance dependence for substances other than cocaine or nicotine
  • Currently seeking treatment for substance abuse/dependence
  • Current or past history of physical disease, impaired cardiovascular functioning, chronic obstructive pulmonary disease
  • History of seizure, head traumas, or central nervous system tumors
  • Current or past history of serious psychiatric disorder other than substance abuse or dependence
  • Family history of cardiovascular disease or seizure disorders

Key Trial Info

Start Date :

August 1 2001

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2005

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT00218166

Start Date

August 1 2001

End Date

May 1 2005

Last Update

January 11 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Kentucky Medical Center

Lexington, Kentucky, United States, 40536 0086